Vietnam To Import GSK Antiviral As Cautionary Move Against H1N1 Flu
This article was originally published in PharmAsia News
Executive Summary
Vietnam authorities have decided to import GlaxoSmithKline's Relenza (zanamivir) for treating the H1N1 flu virus. The purchase of the Australia-developed drug is intended to provide an alternative to Roche's Tamiflu (oseltamivir). A deputy health minister said the price of the drug had not been determined, but the ministry was discussing the matter with GSK. The purchase is being made as a preventative measure, since the more Tamiflu is used, the greater the resistance to it. (Click here for more